Your browser doesn't support javascript.
loading
Removing barriers to accessing medical cannabis for paediatric patients.
Huntsman, Richard J; Elliott, Jesse; Lewis, Evan; Moore-Hepburn, Charlotte; Alcorn, Jane; Mansell, Holly; Appendino, Juan P; Bélanger, Richard E; Corley, Scott; Crooks, Bruce; Denny, AnneMarie M; Finkelstein, Yaron; Finley, Allen; Fung, Ryan; Gilpin, Andrea; Litalien, Catherine; Jacobs, Julia; Oberlander, Timothy F; Palm, Ashley; Palm, Jacob; Polewicz, Monika; Quinn, Declan; Rassekh, S Rod; Repetski, Alexander; Rieder, Michael J; Robson-McKay, Amy; Seifert, Blair; Shackelford, Alan; Siden, Hal; Szafron, Michael; 't Jong, Geert; Vaillancourt, Régis; Kelly, Lauren E.
Afiliación
  • Huntsman RJ; Division of Pediatric Neurology, Department of Pediatrics, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
  • Elliott J; Independent Researcher, Canadian Collaborative for Childhood Cannabinoid Therapeutics, Winnipeg, Manitoba, Canada.
  • Lewis E; Neurology Center of Toronto and Division of Pediatric Neurology, Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada.
  • Moore-Hepburn C; Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada.
  • Alcorn J; College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
  • Mansell H; College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
  • Appendino JP; Division of Pediatric Neurology, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada.
  • Bélanger RE; Départment de Pédiatrie, Faculté de medicine, Université de Laval, Québec, Québec, Canada.
  • Corley S; Cannabinoid Research Initiative of Saskatchewan, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
  • Crooks B; Division of Paediatric Hematology/Oncology, Department of Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Denny AM; Division of Pediatric Neurology, Department of Pediatrics, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
  • Finkelstein Y; Divisions of Emergency Medicine and Clinical Pharmacology and Toxicology, Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada.
  • Finley A; Departments of Anesthesia and Psychology, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Fung R; Department of Pediatric Pharmacy, Saskatchewan Health Authority, Saskatoon, Saskatchewan, Canada.
  • Gilpin A; The Rosalind and Morris Goodman Family Pediatrics Formulation Centre of the CHU Sainte-Justine, Université de Montréal, Montréal, Québec, Canada.
  • Litalien C; Département de Pédiatrie, Faculté de Médecine, Université de Montréal, and The Rosalind and Morris Goodman Family Pediatric Formulation Centre of the CHU Sainte Justine, Montréal, Québec, Canada.
  • Jacobs J; Division of Pediatric Neurology, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada.
  • Oberlander TF; Department of Pediatrics and School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.
  • Palm A; Parent Advocate, Canadian Collaborative for Childhood Cannabinoid Therapeutics, Winnipeg, Manitoba, Canada.
  • Palm J; Parent Advocate, Canadian Collaborative for Childhood Cannabinoid Therapeutics, Winnipeg, Manitoba, Canada.
  • Polewicz M; Division of Pediatric Research, Department of Pediatrics, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
  • Quinn D; Division of Pediatric Psychiatry, Department of Psychiatry, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
  • Rassekh SR; Division of Pediatric Hematology/Oncology/BMT, Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.
  • Repetski A; Parent Advocate, Canadian Collaborative for Childhood Cannabinoid Therapeutics, Winnipeg, Manitoba, Canada.
  • Rieder MJ; Division of Pediatric Pharmacology, Department of Pediatrics, University of Western Ontario, London, Ontario, Canada.
  • Robson-McKay A; Division of Pediatric Psychiatry, Department of Pediatrics, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
  • Seifert B; Department of Pediatric Pharmacy, Saskatchewan Health Authority, Saskatoon, Saskatchewan, Canada.
  • Shackelford A; Amarimed of Colorado, Denver, Colorado, USA.
  • Siden H; Division of Palliative Care, Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.
  • Szafron M; School of Public Health, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
  • 't Jong G; Departments of Pediatrics and Pharmacology, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Vaillancourt R; Department of Pediatric Pharmacy, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada.
  • Kelly LE; George and Fay Yee Centre for Health Care Innovation and Children's Hospital Research Institute of Manitoba, Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Manitoba, Canada.
Paediatr Child Health ; 29(1): 12-16, 2024 Feb.
Article en En | MEDLINE | ID: mdl-38332979
ABSTRACT
Medical cannabis (MC) may offer therapeutic benefits for children with complex neurological conditions and chronic diseases. In Canada, parents, and caregivers frequently report encountering barriers when accessing MC for their children. These include negative preconceived notions about risks and benefits, challenges connecting with a knowledgeable healthcare provider (HCP), the high cost of MC products, and navigating MC product shortages. In this manuscript, we explore several of these barriers and provide recommendations to decision-makers to enable a family-centered and evidence-based approach to MC medicine and research for children.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Año: 2024 Tipo del documento: Article